维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Boxer AL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	An open-label study of memantine treatment in 3 subtypes of frontotemperal lobar degeneration 显示文摘	Boxer AL Lipton AM Womack K	2009	Alzheimer Dis Assoc Disord2009，23，：	1
2	Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment显示文摘	Boxer AL Kramer JH Johnston K	2005	Neurology2005，64，8：	1
3	An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar De- generation 显示文摘	Boxer AL Lipton AM Womack K	2009	Alzheimer Disease & Associated Disorders2009，23，3：	1
4	Frontotemporal dementia treatment:current symptomatic therapies and implications of recent genetic,biochemical,and neuroimaging studies显示文摘	Boxer AL Boeve BF		0，，：	1
5	Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment显示文摘	BOXER AL KRAMER JH JOHNSTON K et a1	2005	Neurology2005，64，8：	1
6	Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia显示文摘	Boxer AL Rankin KP Miller BL	2003	Arch Neurol2003，60，：	1
7	Treatment of frontotemporal dementia显示文摘	TSAI RM BOXER AL	2014	Curr Treat Options Neurol2014，16，11：	1
8	Frontotemporal dementia treatment:current symptomatic therapies and implications of recent genetic,biochemical,and neuroimaging studies显示文摘	Boxer AL Boeve BF	2007	Alzheimer Dis Assoc Disord2007，21，：	1
9	An open-label study of memantine treatment in3subtypes of frontotemporal lobar degeneration显示文摘	Boxer AL Lipton AM Womack K	2009	Alzheimer Dis Assoc Disord2009，23，：	1
10	Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia 显示文摘	Boxer AL Bankin KP Miller BL	2003	Arch Neurol2003，60，7：	1
11	Memantine in patients with frnntotemporal lobar degeneration : a multicentre, randomised, double-blind, placebo- controlled trial 显示文摘	Boxer AL Knopman DS Kaufer DI etal	2013	Lancet Neurol2013，12，：	1
12	Treatment of frontotemporal dementia 显示文摘	Tsai RM Boxer AL	2014	Curr Treat Options Neurol2014，16，11：	1
13	Executive dysfunction inhyperhomocystinemia responds to homocysteine-loweringtreatment显示文摘	Boxer AL Kramer JH Johnston K	2005	Neurology2005，64，：	1
14	Bapineuzumab 显示文摘	Kerchner GA Boxer AL	2010	Expert Opin Biol Ther2010，10，7：	1
15	Frontotemporaldegeneration, the next therapeutic frontier : molecules andanimal models for frontotemporal degeneration drug development显示文摘	BOXER AL GOLD M HUEY E	2013	Alzheimers Dement2013，9，2：	1
16	Patterns of brain at rophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy显示文摘	Boxer AL Geschwind MD Belfor N	2006	Arch Neurol2006，63，1：	1
17	Amyloid imaging in distinguishing atypical pfion disease from Alzheimer disease显示文摘	Boxer AL Rabinovici GD Kepe V	2007	Neurology2007，69，3：	1
18	Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy显示文摘	Boxer AL Geschwind MD Belfor N		0，，：	1
19	FGF-2 potentiates Ca^2+-dependent inactivation of NMDA receptor currents in hippocampal neurons 显示文摘	Boxer AL Moreno H Rudy B	1999	J Neurophysiol1999，82，6：	1
20	Clinical,neuroimaging and neuropathological features of a new chromosome9p-linked FTD-ALS family 显示文摘	Boxer AL Mackenzie IR Boeve BF	2011	J Neurol Neurosurg Psychiatry2011，82，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示